These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18241814)
21. Glycogen storage disease type Ia (GSD Ia) during pregnancy: report of a case complicated by fetal growth restriction and preeclampsia. Yamamoto T; Suzuki Y; Kaneko S; Hattori Y; Obayashi S; Suzumori N; Sugiura M J Obstet Gynaecol Res; 2010 Oct; 36(5):1125-9. PubMed ID: 21058447 [TBL] [Abstract][Full Text] [Related]
22. Sustained high plasma mannose less sensitive to fluctuating blood glucose in glycogen storage disease type Ia children. Nagasaka H; Yorifuji T; Bandsma RH; Takatani T; Asano H; Mochizuki H; Takuwa M; Tsukahara H; Inui A; Tsunoda T; Komatsu H; Hiejima E; Fujisawa T; Hirano K; Miida T; Ohtake A; Taguchi T; Miwa I J Inherit Metab Dis; 2013 Jan; 36(1):75-81. PubMed ID: 22971957 [TBL] [Abstract][Full Text] [Related]
23. A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report. Wang W; Yu R; Tan W; Dan Y; Deng G; Xia J BMC Med Genet; 2019 May; 20(1):85. PubMed ID: 31109299 [TBL] [Abstract][Full Text] [Related]
24. Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease). Wierzbicki AS; Watt GF; Lynas J; Winder AF; Wray R J Inherit Metab Dis; 2001 Oct; 24(5):527-34. PubMed ID: 11757580 [TBL] [Abstract][Full Text] [Related]
25. Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors. Beaty RM; Jackson M; Peterson D; Bird A; Brown T; Benjamin DK; Juopperi T; Kishnani P; Boney A; Chen YT; Koeberl DD Gene Ther; 2002 Aug; 9(15):1015-22. PubMed ID: 12101432 [TBL] [Abstract][Full Text] [Related]
26. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP Eur J Pediatr; 2002 Oct; 161 Suppl 1():S20-34. PubMed ID: 12373567 [TBL] [Abstract][Full Text] [Related]
28. Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia. Bandsma RH; Smit GP; Reijngoud DJ; Kuipers F J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S27-31. PubMed ID: 19267215 [TBL] [Abstract][Full Text] [Related]
29. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases. Liang Y; Du C; Wei H; Zhang C; Zhang M; Hu M; Fang F; Luo X Mol Genet Genomic Med; 2020 Oct; 8(10):e1444. PubMed ID: 32772503 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500 [TBL] [Abstract][Full Text] [Related]
32. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. Brooks ED; Landau DJ; Everitt JI; Brown TT; Grady KM; Waskowicz L; Bass CR; D'Angelo J; Asfaw YG; Williams K; Kishnani PS; Koeberl DD J Inherit Metab Dis; 2018 Nov; 41(6):965-976. PubMed ID: 30043186 [TBL] [Abstract][Full Text] [Related]
33. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. Waskowicz LR; Zhou J; Landau DJ; Brooks ED; Lim A; Yavarow ZA; Kudo T; Zhang H; Wu Y; Grant S; Young SP; Huat BB; Yen PM; Koeberl DD Hum Mol Genet; 2019 Jan; 28(1):143-154. PubMed ID: 30256948 [TBL] [Abstract][Full Text] [Related]
34. Potential use of other starch sources in the treatment of glycogen storage disease type Ia - an in vitro study. Monteiro V; Colonetti K; Pagno CH; Schmidt HO; Sperb-Ludwig F; Oliveira BM; Poloni S; Rios AO; de Souza CFM; Schwartz IVD Orphanet J Rare Dis; 2024 Jul; 19(1):283. PubMed ID: 39080776 [TBL] [Abstract][Full Text] [Related]
35. Molecular prenatal diagnosis of glycogen storage disease type Ia. Qu Y; Abdenur JE; Eng CM; Desnick RJ Prenat Diagn; 1996 Apr; 16(4):333-6. PubMed ID: 8734807 [TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. Faivre L; Houssin D; Valayer J; Brouard J; Hadchouel M; Bernard O J Inherit Metab Dis; 1999 Aug; 22(6):723-32. PubMed ID: 10472532 [TBL] [Abstract][Full Text] [Related]
37. Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia. Marfaing-Koka A; Wolf M; Boyer-Neumann C; Meyer D; Odievre M; Labrune P J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):566-70. PubMed ID: 14581798 [TBL] [Abstract][Full Text] [Related]
38. Preemptive living donor liver transplantation in glycogen storage disease Ia: case report. Kaihara S; Ushigome H; Sakai K; Yoshizawa A; Nobori S; Suzuki T; Okamoto M; Ochiai T; Yoshimura N Transplant Proc; 2008 Oct; 40(8):2815-7. PubMed ID: 18929868 [TBL] [Abstract][Full Text] [Related]
39. Hepatic glycogen storage disorders: what have we learned in recent years? Burda P; Hochuli M Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652 [TBL] [Abstract][Full Text] [Related]
40. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Yekeler E; Dursun M; Emeksiz E; Akkoyunlu M; Akyol Y; Demir F; Gökcay G; Demirkol M Turk J Pediatr; 2007; 49(2):115-9. PubMed ID: 17907509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]